DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $53
Portfolio Pulse from Benzinga Newsdesk
DA Davidson analyst Linda Bolton Weiser has maintained a Neutral rating on Usana Health Sciences (NYSE:USNA) and lowered the price target from $62 to $53.
October 25, 2023 | 4:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Usana Health Sciences' price target has been lowered from $62 to $53 by DA Davidson, while maintaining a Neutral rating.
The lowering of the price target by DA Davidson indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100